Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-09-09
DOI
10.3389/fphar.2016.00303
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice
- (2015) Felipe V. Gomes et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Low expression of Gria1 and Grin1 glutamate receptors in the nucleus accumbens of Spontaneously Hypertensive Rats (SHR)
- (2015) Mariana C. Diana et al. PSYCHIATRY RESEARCH
- Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine
- (2015) J. F. C. Pedrazzi et al. PSYCHOPHARMACOLOGY
- Schizophrenia
- (2014) Anissa Abi-Dargham JOURNAL OF CLINICAL PSYCHIATRY
- Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: The SHR strain
- (2014) Valéria Almeida et al. SCHIZOPHRENIA RESEARCH
- Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain
- (2014) Raquel Levin et al. Frontiers in Pharmacology
- The contextual brain: implications for fear conditioning, extinction and psychopathology
- (2013) Stephen Maren et al. NATURE REVIEWS NEUROSCIENCE
- Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia
- (2013) Jenny Ceccarini et al. NEUROIMAGE
- Mapping Brain Regions in Which Deep Brain Stimulation Affects Schizophrenia-Like Behavior in Two Rat Models of Schizophrenia
- (2012) Julia Klein et al. Brain Stimulation
- Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia
- (2012) Raquel Levin et al. CURRENT PHARMACEUTICAL DESIGN
- Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague–Dawley rats
- (2012) Anand Gururajan et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Impaired Sensorimotor Gating in Unmedicated Adults with Obsessive–Compulsive Disorder
- (2012) Susanne E Ahmari et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test
- (2012) Valéria Almeida et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Effects of antipsychotics and amphetamine on social behaviors in spontaneously hypertensive rats
- (2011) Mariana Bendlin Calzavara et al. BEHAVIOURAL BRAIN RESEARCH
- Effect of cannabidiol in a MK-801-rodent model of aspects of Schizophrenia
- (2011) Anand Gururajan et al. BEHAVIOURAL BRAIN RESEARCH
- Animal models of schizophrenia
- (2011) CA Jones et al. BRITISH JOURNAL OF PHARMACOLOGY
- Paranoid Schizophrenia is Characterized by Increased CB1 Receptor Binding in the Dorsolateral Prefrontal Cortex
- (2011) Victoria S Dalton et al. NEUROPSYCHOPHARMACOLOGY
- Pharmacological and parametrical investigation of prepulse inhibition of startle and prepulse elicited reactions in Wistar rats
- (2011) Jan Brosda et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Spontaneously Hypertensive Rats (SHR) present deficits in prepulse inhibition of startle specifically reverted by clozapine
- (2011) Raquel Levin et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia
- (2011) Sandra L. Matheson et al. SCHIZOPHRENIA RESEARCH
- Acute treatment with cannabinoid receptor agonist WIN55212.2 improves prepulse inhibition in psychosocially stressed mice
- (2010) Magdalena M. Brzózka et al. BEHAVIOURAL BRAIN RESEARCH
- Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR
- (2010) Dean F. Wong et al. NEUROIMAGE
- Brain Cannabinoid CB2 Receptor in Schizophrenia
- (2009) Hiroki Ishiguro et al. BIOLOGICAL PSYCHIATRY
- Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis
- (2009) Dagmar Koethe et al. BRITISH JOURNAL OF PSYCHIATRY
- Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats
- (2009) Maria Sabrina Spano et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A behavioural comparison of acute and chronic Δ9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice
- (2009) Leonora E. Long et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Adolescent and Adult Male Spontaneous Hyperactive Rats (SHR) Respond Differently to Acute and Chronic Methylphenidate (Ritalin)
- (2009) Elyssa Barron et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol reverses the reduction in social interaction produced by low dose Δ9-tetrahydrocannabinol in rats
- (2009) Daniel Thomas Malone et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning
- (2009) P. D. Morrison et al. PSYCHOLOGICAL MEDICINE
- What We Know: Findings That Every Theory of Schizophrenia Should Explain
- (2009) A. W. MacDonald et al. SCHIZOPHRENIA BULLETIN
- The relationship between prepulse inhibition and general psychopathology in patients with schizophrenia treated with long-acting risperidone
- (2009) Isabel Martinez-Gras et al. SCHIZOPHRENIA RESEARCH
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- (2009) Angelo A. Izzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia
- (2008) Iván Chavarría-Siles et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment
- (2008) Nico Wegener et al. BRAIN RESEARCH
- Cannabidiol for the treatment of psychosis in Parkinson’s disease
- (2008) AW Zuardi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effects of acute systemic and intra-cerebral stimulation of cannabinoid receptors on sensorimotor gating, locomotion and spatial memory in rats
- (2008) Nico Wegener et al. PSYCHOPHARMACOLOGY
- Realistic expectations of prepulse inhibition in translational models for schizophrenia research
- (2008) Neal R. Swerdlow et al. PSYCHOPHARMACOLOGY
- Neuroleptic Drugs Revert the Contextual Fear Conditioning Deficit Presented by Spontaneously Hypertensive Rats: A Potential Animal Model of Emotional Context Processing in Schizophrenia?
- (2008) M. B. Calzavara et al. SCHIZOPHRENIA BULLETIN
- Uncontrollable voices and their relationship to gating deficits in schizophrenia
- (2008) Veena Kumari et al. SCHIZOPHRENIA RESEARCH
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now